ALZNVSBTAI• 12 Months (Normalized)
ALZN vs BTAI (Alzamend Neuro Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Sep, 16, 2025 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ALZN Performance $1.83
-30.15%
Alzamend Neuro Inc.
Normalized Baseline0.00%
BTAI Performance $0.07
-97.76%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ALZN LEADS
+67.61%
ALZN outperforming by 67.61%
ALZNBTAI
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ALZN BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ALZN Price | ALZN Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.83 | -30.15% | $0.07 | -97.76% | +67.61% |
| Sep 15, 2026 | $1.78 | -32.06% | $0.04 | -98.51% | +66.45% |
| Sep 14, 2026 | $1.75 | -33.21% | $0.05 | -98.49% | +65.28% |
| Sep 11, 2026 | $1.72 | -34.35% | $0.05 | -98.29% | +63.94% |
| Sep 10, 2026 | $1.70 | -35.11% | $0.05 | -98.33% | +63.22% |
| Sep 09, 2026 | $1.68 | -35.88% | $0.05 | -98.43% | +62.55% |
| Sep 08, 2026 | $1.68 | -35.88% | $0.04 | -98.56% | +62.68% |
| Sep 04, 2026 | $1.66 | -36.64% | $0.07 | -97.53% | +60.89% |
| Sep 03, 2026 | $1.70 | -35.11% | $0.12 | -96.05% | +60.94% |
| Sep 02, 2026 | $1.70 | -35.11% | $0.11 | -96.42% | +61.31% |
| Sep 01, 2026 | $1.64 | -37.52% | $0.14 | -95.42% | +57.90% |
| Aug 31, 2026 | $1.60 | -38.93% | $0.16 | -94.55% | +55.62% |
| Aug 28, 2026 | $1.66 | -36.64% | $0.18 | -93.95% | +57.31% |
| Aug 27, 2026 | $1.67 | -36.45% | $0.72 | -75.95% | +39.50% |
| Aug 26, 2026 | $1.67 | -36.26% | $0.78 | -73.91% | +37.65% |
Page 1 of 17